Search - Université de Rennes Access content directly

Filter your results

18 Results
Author: personID (integer) : 780500

Hilar Fat Infiltration: An Independent Prognostic Factor in Metastatic Clear Cell Renal Cell Carcinoma with Sunitinib First-Line Treatment

Solène-Florence Kammerer-Jacquet , Angélique Brunot , Karim Benasalah , Boris Campillo-Gimenez , Mathilde Lefort et al.
Laboratory Investigation, 2017, 97, pp.234A--234A
Journal articles hal-01500477v1
Image document

Sex differences in adherence to antihypertensive treatment in patients aged above 55 The French League Against Hypertension Survey (FLAHS)

Mathilde Lefort , Lola Neufcourt , Bruno Pannier , Bernard Vaisse , Sahar Bayat et al.
Journal of Clinical Hypertension, 2018, 20 (10), pp.1496-1503. ⟨10.1111/jch.13387⟩
Journal articles hal-01939728v1
Image document

Disability Progression in Multiple Sclerosis Patients using Early First-line Treatments

Mathilde Lefort , Sandra Vukusic , Romain Casey , Gilles Edan , Emmanuelle Leray et al.
European Journal of Neurology, 2022, 29 (9), pp.2761-2771. ⟨10.1111/ene.15422⟩
Journal articles hal-03690316v1

Two-year management after renal transplantation in 2013 in France: Input from the French national health system database

Nolwenn Le Meur , Mathilde Lefort , Saïd Lebbah , Jean-Philippe Jais , Eric Daugas et al.
Néphrologie & Thérapeutique, 2018, 14 (4), pp.207-216. ⟨10.1016/j.nephro.2017.11.006⟩
Journal articles hal-02445434v1
Image document

Trends in disease-modifying therapy use in patients with multiple sclerosis using a 10-year population-based cohort study in France

Soline Leblanc , Mathilde Lefort , Emmanuelle Le Page , Laure Michel , Emmanuelle Leray et al.
Expert Review of Neurotherapeutics, 2022, 22 (5), pp.411-418. ⟨10.1080/14737175.2022.2061950⟩
Journal articles hal-03629848v1

Descriptif des caractéristiques des personnes ayant une sclérose en plaques en France et de leur recours aux soins à partir du Système National des Données de Santé en 2010-2015

Jonathan Roux , Alice Guilleux , Mathilde Lefort , Emmanuelle Leray
Revue Neurologique, 2019, 175 (N° S1), pp.S86-S87. ⟨10.1016/j.neurol.2019.01.241⟩
Journal articles hal-02921515v1
Image document

A cross-sectional study on infectious health risks regarding freshwater sports practice in Brittany, France

Fanny Velardo , Hanifa Bouziri , Lucie Adélaïde , Emma Oliosi , Maylis Layan et al.
Journal of Water and Health, 2022, 20 (2), pp.356-368. ⟨10.2166/wh.2022.232⟩
Journal articles hal-03554882v1
Image document

Facilitating access to the renal transplant waiting list does not increase the number of transplantations: comparative study of two French regions

Mathilde Lefort , Cécile Vigneau , Annelen Laurent , Saïd Lebbah , Nolwenn Le Meur et al.
Clinical Kidney Journal, 2016, 9 (6), pp.849-857. ⟨10.1093/ckj/sfw078⟩
Journal articles hal-01439362v1
Image document

Impact de la crise sanitaire de la COVID-19 sur la santé mentale des étudiants à Rennes, France

Jonathan Roux , Mathilde Lefort , Mélanie Bertin , Cindy Padilla , Judith Mueller et al.
2021
Preprints, Working Papers, ... hal-03172226v1
Image document

Hilar fat infiltration: A new prognostic factor in metastatic clear cell renal cell carcinoma with first-line sunitinib treatment

Solene-Florence Kammerer-Jacquet , Angélique Brunot , Karim Bensalah , Boris Campillo-Gimenez , Mathilde Lefort et al.
Urologic Oncology: Seminars and Original Investigations, 2017, 35 (10), pp.603.e7 - 603.e14. ⟨10.1016/j.urolonc.2017.05.015⟩
Journal articles hal-01632553v1

Propensity score methods The study of the effect of beta-interferon and glatiramer acetate on multiple sclerosis disability

Mathilde Lefort , Gilles Edan , Emmanuelle Leray
Pharmacoepidemiology and Drug Safety, 2018, 27, pp.191-192
Journal articles hal-01879623v1

Nomogram Predicting Prognosis in Metastatic Patients with Clear Cell Renal Cell Carcinoma Treated by First-Line Sunitinib

Solène-Florence Kammerer-Jacquet , Frédéric Dugay , Karim Bensalah , Angélique Brunot , Benoit Peyronnet et al.
Laboratory Investigation, 2017, 97, pp.234A--234A
Journal articles hal-01500476v1
Image document

The effectiveness of natalizumab vs fingolimod–A comparison of international registry studies

Johanna Andersen , Sifat Sharmin , Mathilde Lefort , Nils Koch-Henriksen , Finn Sellebjerg et al.
Multiple Sclerosis and Related Disorders, 2021, 53, pp.103012. ⟨10.1016/j.msard.2021.103012⟩
Journal articles hal-03268539v1
Image document

Categorical state sequence analysis and regression tree to identify determinants of care trajectory in chronic disease: Example of end-stage renal disease

Nolwenn Le Meur , Cécile Vigneau , Mathilde Lefort , Saïd Lebbah , Jean-Philippe Jais et al.
Statistical Methods in Medical Research, 2019, 28 (6), pp.1731-1740. ⟨10.1177/0962280218774811⟩
Journal articles hal-01792740v1

Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts

Sifat Sharmin , Mathilde Lefort , Johanna Balslev Andersen , Emmanuelle Leray , Dana Horakova et al.
CNS Drugs, 2021, 35 (11), pp.1217-1232. ⟨10.1007/s40263-021-00860-7⟩
Journal articles hal-03367246v1
Image document

Etude de l'effet des stratégies thérapeutiques en conditions réelles d'utilisation sur la progression du handicap chez les patients atteints de sclérose en plaques rémittente

Mathilde Lefort
Médecine humaine et pathologie. Université de Rennes, 2019. Français. ⟨NNT : 2019REN1B050⟩
Theses tel-03510267v1

Effet de l’initiation précoce d’un traitement de fond sur la progression du handicap en sclérose en plaques rémittente : une étude observationnelle des données de l’OFSEP

Mathilde Lefort , Vukusic Sandra , Romain Casey , Gilles Edan , Emmanuelle Leray et al.
Revue Neurologique, 2019, 175, pp.S87. ⟨10.1016/j.neurol.2019.01.243⟩
Journal articles hal-02921500v1

Long-term effect of interferon and Glatiramer acetate in real-world settings use on multiple sclerosis disability progression: Input of time-dependent propensity score

Mathilde Lefort , Yohann Foucher , Rémi Lenain , Sandra Vukusic , Gilles Edan et al.
Pharmacoepidemiology and Drug Safety, 2019, 28, pp.217-218
Journal articles hal-02302564v1